Next Article in Journal
Management of Anti-Seizure Medications during Pregnancy: Advancements in The Past Decade
Next Article in Special Issue
Association of HLA-G 3′UTR Polymorphisms with Response to First-Line FOLFIRI Treatment in Metastatic Colorectal Cancer
Previous Article in Journal
Model-Informed Precision Dosing (MIPD)
Previous Article in Special Issue
Exploiting the DNA Damaging Activity of Liposomal Low Dose Cytarabine for Cancer Immunotherapy
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(12), 2732; https://doi.org/10.3390/pharmaceutics14122732
Action Date Notes Link
article pdf uploaded. 6 December 2022 14:23 CET Version of Record https://www.mdpi.com/1999-4923/14/12/2732/pdf-vor
article xml file uploaded 8 December 2022 04:53 CET Original file -
article xml uploaded. 8 December 2022 04:53 CET Update https://www.mdpi.com/1999-4923/14/12/2732/xml
article pdf uploaded. 8 December 2022 04:53 CET Updated version of record https://www.mdpi.com/1999-4923/14/12/2732/pdf
article html file updated 8 December 2022 04:55 CET Original file -
article html file updated 1 March 2023 02:51 CET Update -
article html file updated 4 March 2023 01:44 CET Update https://www.mdpi.com/1999-4923/14/12/2732/html
Back to TopTop